000			01910 a2200505 4500
005			20250517014709.0
264		0	_c20160310
008			201603s 0 0 eng d
022			_a1533-4023
024	7		_a10.1097/FJC.0000000000000190 _2doi
040			_aNLM _beng _cNLM
100	1		_aEllmers, Leigh J
245	0	0	_aChronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction. _h[electronic resource]
260			_bJournal of cardiovascular pharmacology _cMar 2015
300			_a269-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCardiotonic Agents _xpharmacology
650	0	4	_aCollagen Type I _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aFibrosis
650	0	4	_aGene Expression Regulation
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHypertrophy, Left Ventricular _xgenetics
650	0	4	_aMale
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMyocardial Contraction _xdrug effects
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aMyosin Heavy Chains _xgenetics
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRecovery of Function
650	0	4	_aStroke Volume _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aUrocortins _xpharmacology
650	0	4	_aVentricular Dysfunction, Left _xgenetics
650	0	4	_aVentricular Function, Left _xdrug effects
650	0	4	_aVentricular Remodeling _xdrug effects
700	1		_aScott, Nicola J A
700	1		_aCameron, Vicky A
700	1		_aRichards, A Mark
700	1		_aRademaker, Miriam T
773	0		_tJournal of cardiovascular pharmacology _gvol. 65 _gno. 3 _gp. 269-75
856	4	0	_uhttps://doi.org/10.1097/FJC.0000000000000190 _zAvailable from publisher's website
999			_c24601012 _d24601012